Literature DB >> 29283893

Out-of-system Care and Recording of Patient Characteristics Critical for Comparative Effectiveness Research.

Kueiyu Joshua Lin, Robert J Glynn, Daniel E Singer, Shawn N Murphy, Joyce Lii, Sebastian Schneeweiss.   

Abstract

BACKGROUND: It is unclear how out-of-system care or electronic health record (EHR) discontinuity (i.e., receiving care outside of an EHR system) may affect validity of comparative effectiveness research using these data. We aimed to compare the misclassification of key variables in patients with high versus low EHR continuity.
METHODS: The study cohort comprised patients ages ≥65 identified in electronic health records from two US provider networks linked with Medicare insurance claims data from 2007 to 2014. By comparing electronic health records and claims data, we quantified EHR continuity by the proportion of encounters captured by the EHRs (i.e., "capture proportion"). Within levels of EHR continuity, for 40 key variables, we quantified misclassification by mean standardized differences between coding based on EHRs alone versus linked claims and EHR data.
RESULTS: Based on 183,739 patients, we found that mean capture proportion in a single electronic health record system was 16%-27% across two provider networks. Patients with highest level of EHR continuity (capture proportion ≥ 80%) had 11.4- to 17.4-fold less variable misclassification, when compared with those with lowest level of EHR continuity (capture proportion< 10%). Capturing at least 60% of the encounters in an EHR system was required to have reasonable variable classification (mean standardized difference <0.1). We found modest differences in comorbidity profiles between patients with high and low EHR continuity.
CONCLUSIONS: EHR discontinuity may lead to substantial misclassification in key variables. Restricting comparative effectiveness research to patients with high EHR continuity may confer a favorable benefit (reducing information bias) to risk (losing generalizability) ratio.

Entities:  

Mesh:

Year:  2018        PMID: 29283893      PMCID: PMC5882528          DOI: 10.1097/EDE.0000000000000794

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  17 in total

Review 1.  Use of health care databases in pharmacoepidemiology.

Authors:  Sean Hennessy
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-03       Impact factor: 4.080

2.  Metrics for covariate balance in cohort studies of causal effects.

Authors:  Jessica M Franklin; Jeremy A Rassen; Diana Ackermann; Dorothee B Bartels; Sebastian Schneeweiss
Journal:  Stat Med       Date:  2013-12-09       Impact factor: 2.373

3.  Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.

Authors:  Margaret C Fang; Dongjie Fan; Sue Hee Sung; Daniel M Witt; John R Schmelzer; Steven R Steinhubl; Steven H Yale; Alan S Go
Journal:  Med Care       Date:  2017-12       Impact factor: 2.983

Review 4.  A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.

Authors:  Leonardo Tamariz; Thomas Harkins; Vinit Nair
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01       Impact factor: 2.890

5.  A combined comorbidity score predicted mortality in elderly patients better than existing scores.

Authors:  Joshua J Gagne; Robert J Glynn; Jerry Avorn; Raisa Levin; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2011-01-05       Impact factor: 6.437

6.  Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure.

Authors:  Sushrut S Waikar; Ron Wald; Glenn M Chertow; Gary C Curhan; Wolfgang C Winkelmayer; Orfeas Liangos; Marie-Anne Sosa; Bertrand L Jaber
Journal:  J Am Soc Nephrol       Date:  2006-04-26       Impact factor: 10.121

7.  Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.

Authors:  Elena Birman-Deych; Amy D Waterman; Yan Yan; David S Nilasena; Martha J Radford; Brian F Gage
Journal:  Med Care       Date:  2005-05       Impact factor: 2.983

8.  Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population.

Authors:  Peter M Wahl; Keith Rodgers; Sebastian Schneeweiss; Brian F Gage; Javed Butler; Charles Wilmer; Marshall Nash; Gregory Esper; Norman Gitlin; Neal Osborn; Louise J Short; Rhonda L Bohn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-06       Impact factor: 2.890

9.  Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2009-11-10       Impact factor: 2.373

10.  Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data.

Authors:  Robert P Myers; Yvette Leung; Abdel Aziz M Shaheen; Bing Li
Journal:  BMC Health Serv Res       Date:  2007-10-02       Impact factor: 2.655

View more
  18 in total

1.  Stepped-wedge randomised trial to evaluate population health intervention designed to increase appropriate anticoagulation in patients with atrial fibrillation.

Authors:  Shirley V Wang; James R Rogers; Yinzhu Jin; David DeiCicchi; Sara Dejene; Jean M Connors; David W Bates; Robert J Glynn; Michael A Fischer
Journal:  BMJ Qual Saf       Date:  2019-06-26       Impact factor: 7.035

2.  Oncology Drug Effectiveness from Electronic Health Record Data Calibrated Against RCT Evidence: The PARSIFAL Trial Emulation.

Authors:  David Merola; Jessica Young; Deborah Schrag; Kueiyu Joshua Lin; Nicholas Robert; Sebastian Schneeweiss
Journal:  Clin Epidemiol       Date:  2022-10-10       Impact factor: 5.814

3.  Measurement error and misclassification in electronic medical records: methods to mitigate bias.

Authors:  Jessica C Young; Mitchell M Conover; Michele Jonsson Funk
Journal:  Curr Epidemiol Rep       Date:  2018-09-10

4.  Considerations for observational study design: Comparing the evidence of opioid use between electronic health records and insurance claims.

Authors:  Jessica C Young; Nabarun Dasgupta; Til Stürmer; Virginia Pate; Michele Jonsson Funk
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-05-23       Impact factor: 2.732

5.  Using machine learning to identify health outcomes from electronic health record data.

Authors:  Jenna Wong; Mara Murray Horwitz; Li Zhou; Sengwee Toh
Journal:  Curr Epidemiol Rep       Date:  2018-09-20

6.  Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.

Authors:  Jessica M Franklin; Elisabetta Patorno; Rishi J Desai; Robert J Glynn; David Martin; Kenneth Quinto; Ajinkya Pawar; Lily G Bessette; Hemin Lee; Elizabeth M Garry; Nileesa Gautam; Sebastian Schneeweiss
Journal:  Circulation       Date:  2020-12-17       Impact factor: 29.690

7.  Longitudinal Data Discontinuity in Electronic Health Records and Consequences for Medication Effectiveness Studies.

Authors:  Kueiyu Joshua Lin; Yinzhu Jin; Joshua Gagne; Robert J Glynn; Shawn N Murphy; Angela Tong; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2021-09-20       Impact factor: 6.875

8.  Bias Reduction Methods for Propensity Scores Estimated from Error-Prone EHR-Derived Covariates.

Authors:  Joanna Harton; Ronac Mamtani; Nandita Mitra; Rebecca A Hubbard
Journal:  Health Serv Outcomes Res Methodol       Date:  2020-09-10

9.  Characterizing Bias Due to Differential Exposure Ascertainment in Electronic Health Record Data.

Authors:  Rebecca A Hubbard; Elle Lett; Gloria Y F Ho; Jessica Chubak
Journal:  Health Serv Outcomes Res Methodol       Date:  2021-01-04

10.  External Validation of an Algorithm to Identify Patients with High Data-Completeness in Electronic Health Records for Comparative Effectiveness Research.

Authors:  Kueiyu Joshua Lin; Gary E Rosenthal; Shawn N Murphy; Kenneth D Mandl; Yinzhu Jin; Robert J Glynn; Sebastian Schneeweiss
Journal:  Clin Epidemiol       Date:  2020-02-04       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.